Click for best price

Antibody Drug Conjugate Market Size, Share 2024

The global Antibody Drug Conjugate market size is estimated to be $xx million in 2023, and it will reach $xx million by 2032, growing at a CAGR of xx% during the forecast period from 2024 to 2032.

This report studies the Antibody Drug Conjugate market, covering market size for segment by type (Cleavable Linker, Non-cleavable Linker, etc.), by application (Blood Cancer, Breast Cancer, etc.), by sales channel (Direct Channel, Distribution Channel), by player (AbbVie, Agensys, Amgen, Bayer HealthCare, Celldex Therapeutics, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).

This report provides detailed historical analysis of global market for Antibody Drug Conjugate from 2018-2023, and provides extensive market forecasts from 2024-2032 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Antibody Drug Conjugate market.

Leading Players of Antibody Drug Conjugate including:

AbbVie

Agensys

Amgen

Bayer HealthCare

Celldex Therapeutics

Concortis Biotherapeutics

Eli Lilly

Genentech

Genmab

Heidelberg Pharma

ImmunoGen

Immunomedics

Mersana Therapeutics

Millennium Pharmaceuticals

Novartis

Oxford Bio Therapeutics

Pfizer

Progenics Pharmaceuticals

Roche

Sanofi

Seattle Genetics

Synthon Holding

Takeda Pharmaceutical

Market split by Type:

Cleavable Linker

Non-cleavable Linker

Market split by Application:

Blood Cancer

Breast Cancer

Ovarian Cancer

Lung Cancer

Brain Tumor

Market split by Sales Channel:

Direct Channel

Distribution Channel

Market split by Region/Country:

North America (United States and Canada)

Europe (Germany, UK, France, Italy, Spain, and Russia, etc.)

Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia, etc.)

South America (Brazil, Mexico, and Argentina, etc.)

Middle East & Africa (Turkey, UAE, Saudi Arabia, and South Africa, etc.)

If you have any special requirements, please let us know and we can provide you the customized report as you want.

Report Attributes	Report Details
Report Title	Antibody Drug Conjugate Market 2024-2030 by Player, Region, Type, Application and Sales Channel
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2023
Forecast Year	2031
Number of Pages	120 Pages
Customization Available	Yes, the report can be customized as per your need.

Table of Contents

Chapter 1 Antibody Drug Conjugate Market Overview
1.1 Antibody Drug Conjugate Definition
1.2 Global Antibody Drug Conjugate Market Size Status and Outlook (2018-2032)
1.3 Global Antibody Drug Conjugate Market Size Comparison by Region (2018-2032)
1.4 Global Antibody Drug Conjugate Market Size Comparison by Type (2018-2032)
1.5 Global Antibody Drug Conjugate Market Size Comparison by Application (2018-2032)
1.6 Global Antibody Drug Conjugate Market Size Comparison by Sales Channel (2018-2032)
1.7 Antibody Drug Conjugate Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Merger/Acquisition/Expansion)
1.7.4 Key Trends in Antibody Drug Conjugate Market
Chapter 2 Antibody Drug Conjugate Market Competition by Player
2.1 Global Antibody Drug Conjugate Sales and Market Share by Player (2021-2023)
2.2 Global Antibody Drug Conjugate Revenue and Market Share by Player (2021-2023)
2.3 Global Antibody Drug Conjugate Average Price by Player (2021-2023)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Antibody Drug Conjugate Market Segment by Type
3.1 Global Antibody Drug Conjugate Market by Type
3.1.1 Cleavable Linker
3.1.2 Non-cleavable Linker
3.2 Global Antibody Drug Conjugate Sales and Market Share by Type (2018-2023)
3.3 Global Antibody Drug Conjugate Revenue and Market Share by Type (2018-2023)
3.4 Global Antibody Drug Conjugate Average Price by Type (2018-2023)
3.5 Conclusion of Segment by Type
Chapter 4 Antibody Drug Conjugate Market Segment by Application
4.1 Global Antibody Drug Conjugate Market by Application
4.1.1 Blood Cancer
4.1.2 Breast Cancer
4.1.3 Ovarian Cancer
4.1.4 Lung Cancer
4.1.5 Brain Tumor
4.2 Global Antibody Drug Conjugate Revenue and Market Share by Application (2018-2023)
4.3 Conclusion of Segment by Application
Chapter 5 Antibody Drug Conjugate Market Segment by Sales Channel
5.1 Global Antibody Drug Conjugate Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Antibody Drug Conjugate Revenue and Market Share by Sales Channel (2018-2023)
5.3 Conclusion of Segment by Sales Channel
Chapter 6 Antibody Drug Conjugate Market Segment by Region & Country
6.1 Global Antibody Drug Conjugate Market Size and CAGR by Region (2018-2032)
6.2 Global Antibody Drug Conjugate Sales and Market Share by Region (2018-2023)
6.3 Global Antibody Drug Conjugate Revenue and Market Share by Region (2018-2023)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Antibody Drug Conjugate Market Share by Type
6.4.3 North America Antibody Drug Conjugate Market Share by Application
6.4.4 United States
6.4.5 Canada
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Antibody Drug Conjugate Market Share by Type
6.5.3 Europe Antibody Drug Conjugate Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Spain
6.5.9 Russia
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Antibody Drug Conjugate Market Share by Type
6.6.3 Asia-Pacific Antibody Drug Conjugate Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Antibody Drug Conjugate Market Share by Type
6.7.3 South America Antibody Drug Conjugate Market Share by Application
6.7.4 Brazil
6.7.5 Mexico
6.7.6 Argentina
6.7.7 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Antibody Drug Conjugate Market Share by Type
6.8.3 Middle East & Africa Antibody Drug Conjugate Market Share by Application
6.8.4 Turkey
6.8.5 UAE
6.8.6 Saudi Arabia
6.8.7 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Antibody Drug Conjugate Players
7.1 AbbVie
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Agensys
7.3 Amgen
7.4 Bayer HealthCare
7.5 Celldex Therapeutics
7.6 Concortis Biotherapeutics
7.7 Eli Lilly
7.8 Genentech
7.9 Genmab
7.10 Heidelberg Pharma
7.11 ImmunoGen
7.12 Immunomedics
7.13 Mersana Therapeutics
7.14 Millennium Pharmaceuticals
7.15 Novartis
7.16 Oxford Bio Therapeutics
7.17 Pfizer
7.18 Progenics Pharmaceuticals
7.19 Roche
7.20 Sanofi
7.21 Seattle Genetics
7.22 Synthon Holding
7.23 Takeda Pharmaceutical
Chapter 8 Upstream and Downstream Analysis of Antibody Drug Conjugate
8.1 Industrial Chain of Antibody Drug Conjugate
8.2 Upstream of Antibody Drug Conjugate
8.3 Downstream of Antibody Drug Conjugate
Chapter 9 Development Trend of Antibody Drug Conjugate (2024-2032)
9.1 Global Antibody Drug Conjugate Market Size (Sales and Revenue) Forecast (2024-2032)
9.2 Global Antibody Drug Conjugate Market Size and CAGR Forecast by Region (2024-2032)
9.3 Global Antibody Drug Conjugate Market Size and CAGR Forecast by Type (2024-2032)
9.4 Global Antibody Drug Conjugate Market Size and CAGR Forecast by Application (2024-2032)
9.5 Global Antibody Drug Conjugate Market Size and CAGR Forecast by Sales Channel (2024-2032)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification

LIST OF TABLES & FIGURES

List of Tables and Figures

Figure Antibody Drug Conjugate Example
Figure Global Antibody Drug Conjugate Revenue (Million $) Status and Outlook (2018-2032)
Figure Global Antibody Drug Conjugate Revenue (Million $) Comparison by Region (2018-2032)
Figure Global Antibody Drug Conjugate Revenue (Million $) Comparison by Type (2018-2032)
Figure Global Antibody Drug Conjugate Revenue (Million $) Comparison by Application (2018-2032)
Figure Global Antibody Drug Conjugate Revenue (Million $) Comparison by Sales Channel (2018-2032)
Table Global Antibody Drug Conjugate Sales by Player (2021-2023)
Table Global Antibody Drug Conjugate Sales Market Share by Player (2021-2023)
Figure Global Antibody Drug Conjugate Sales Market Share by Player in 2023
Table Global Antibody Drug Conjugate Revenue (Million $) by Player (2021-2023)
Table Global Antibody Drug Conjugate Revenue Market Share by Player (2021-2023)
Figure Global Antibody Drug Conjugate Revenue Market Share by Player in 2023
Table Global Antibody Drug Conjugate Average Price by Player (2021-2023)
Figure Global Antibody Drug Conjugate Average Price by Player in 2023
Figure Global Antibody Drug Conjugate Players Competition Situation ? Top 5 Players? Revenue Market Share in 2021
Figure Global Antibody Drug Conjugate Players Competition Trends ? Top 5 Players? Revenue Market Share in 2023
Figure Example of Cleavable Linker
Figure Global Cleavable Linker Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Non-cleavable Linker
Figure Global Non-cleavable Linker Revenue (Million $) and Growth Rate (2018-2023)
Table Global Antibody Drug Conjugate Sales by Type (2018-2023)
Table Global Antibody Drug Conjugate Sales Market Share by Type (2018-2023)
Figure Global Antibody Drug Conjugate Sales Market Share by Type in 2023
Table Global Antibody Drug Conjugate Revenue (Million $) by Type (2018-2023)
Table Global Antibody Drug Conjugate Revenue Market Share by Type (2018-2023)
Figure Global Antibody Drug Conjugate Revenue Market Share by Type in 2023
Table Global Antibody Drug Conjugate Average Price by Type (2018-2023)
Figure Global Antibody Drug Conjugate Average Price by Type in 2023
Table Leading Players of Antibody Drug Conjugate by Type in 2023
Figure Example of Blood Cancer
Figure Global Antibody Drug Conjugate for Blood Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Breast Cancer
Figure Global Antibody Drug Conjugate for Breast Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Ovarian Cancer
Figure Global Antibody Drug Conjugate for Ovarian Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Lung Cancer
Figure Global Antibody Drug Conjugate for Lung Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Brain Tumor
Figure Global Antibody Drug Conjugate for Brain Tumor Revenue (Million $) and Growth Rate (2018-2023)
Table Global Antibody Drug Conjugate Sales by Application (2018-2023)
Table Global Antibody Drug Conjugate Sales Market Share by Application (2018-2023)
Figure Global Antibody Drug Conjugate Sales Market Share by Application in 2023
Table Leading Consumers of Antibody Drug Conjugate by Application in 2023
Figure Example of Direct Channel
Figure Global Antibody Drug Conjugate for Direct Channel Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Distribution Channel
Figure Global Antibody Drug Conjugate for Distribution Channel Revenue (Million $) and Growth Rate (2018-2023)
Table Global Antibody Drug Conjugate Revenue by Sales Channel (2018-2023)
Table Global Antibody Drug Conjugate Revenue Market Share by Sales Channel (2018-2023)
Figure Global Antibody Drug Conjugate Revenue Market Share by Sales Channel in 2023
Table Leading Distributors/Dealers of Antibody Drug Conjugate by Sales Channel in 2023
Table Global Antibody Drug Conjugate Market Size and CAGR by Region (2018-2032)
Table Global Antibody Drug Conjugate Sales by Region (2018-2023)
Table Global Antibody Drug Conjugate Sales Market Share by Region (2018-2023)
Figure Global Antibody Drug Conjugate Sales Market Share by Region in 2023
Table Global Antibody Drug Conjugate Revenue (Million $) by Region (2018-2023)
Table Global Antibody Drug Conjugate Revenue Market Share by Region (2018-2023)
Figure Global Antibody Drug Conjugate Revenue Market Share by Region in 2023
Table North America Antibody Drug Conjugate Sales by Country (2018-2023)
Figure North America Antibody Drug Conjugate Sales Market Share by Country (2018-2023)
Table North America Antibody Drug Conjugate Revenue by Country (2018-2023)
Figure North America Antibody Drug Conjugate Revenue Market Share by Country (2018-2023)
Figure North America Antibody Drug Conjugate Market Share by Type in 2023
Figure North America Antibody Drug Conjugate Market Share by Application in 2023
Figure United States Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure United States Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Figure Canada Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure Canada Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Table Europe Antibody Drug Conjugate Sales by Country (2018-2023)
Figure Europe Antibody Drug Conjugate Sales Market Share by Country (2018-2023)
Table Europe Antibody Drug Conjugate Revenue by Country (2018-2023)
Figure Europe Antibody Drug Conjugate Revenue Market Share by Country (2018-2023)
Figure Europe Antibody Drug Conjugate Market Share by Type in 2023
Figure Europe Antibody Drug Conjugate Market Share by Application in 2023
Figure Germany Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure Germany Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Figure UK Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure UK Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Figure France Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure France Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Figure Italy Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure Italy Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Figure Spain Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure Spain Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Figure Russia Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure Russia Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Table Asia-Pacific Antibody Drug Conjugate Sales by Country (2018-2023)
Figure Asia-Pacific Antibody Drug Conjugate Sales Market Share by Country (2018-2023)
Table Asia-Pacific Antibody Drug Conjugate Revenue by Country (2018-2023)
Figure Asia-Pacific Antibody Drug Conjugate Revenue Market Share by Country (2018-2023)
Figure Asia-Pacific Antibody Drug Conjugate Market Share by Type in 2023
Figure Asia-Pacific Antibody Drug Conjugate Market Share by Application in 2023
Figure China Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure China Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Figure Japan Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure Japan Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Figure Korea Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure Korea Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Figure India Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure India Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Figure Southeast Asia Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure Southeast Asia Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Figure Australia Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure Australia Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Table South America Antibody Drug Conjugate Sales by Country (2018-2023)
Figure South America Antibody Drug Conjugate Sales Market Share by Country (2018-2023)
Table South America Antibody Drug Conjugate Revenue by Country (2018-2023)
Figure South America Antibody Drug Conjugate Revenue Market Share by Country (2018-2023)
Figure South America Antibody Drug Conjugate Market Share by Type in 2023
Figure South America Antibody Drug Conjugate Market Share by Application in 2023
Figure Brazil Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure Brazil Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Figure Mexico Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure Mexico Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Figure Argentina Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure Argentina Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Figure Colombia Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure Colombia Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Table Middle East & Africa Antibody Drug Conjugate Sales by Country (2018-2023)
Figure Middle East & Africa Antibody Drug Conjugate Sales Market Share by Country (2018-2023)
Table Middle East & Africa Antibody Drug Conjugate Revenue by Country (2018-2023)
Figure Middle East & Africa Antibody Drug Conjugate Revenue Market Share by Country (2018-2023)
Figure Middle East & Africa Antibody Drug Conjugate Market Share by Type in 2023
Figure Middle East & Africa Antibody Drug Conjugate Market Share by Application in 2023
Figure Turkey Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure Turkey Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Figure UAE Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure UAE Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Figure Saudi Arabia Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure Saudi Arabia Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Figure South Africa Antibody Drug Conjugate Sales and Growth Rate (2018-2023)
Figure South Africa Antibody Drug Conjugate Revenue (Million $) and Growth Rate (2018-2023)
Table Company Snapshot of AbbVie
Table Antibody Drug Conjugate Introduction of AbbVie
Table Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share of AbbVie (2021-2023)
Table Industrial Chain of Antibody Drug Conjugate
Table Leading Consumers of Antibody Drug Conjugate
Figure Global Antibody Drug Conjugate Sales and Growth Rate Forecast (2024-2032)
Figure Global Antibody Drug Conjugate Revenue and Growth Rate Forecast (2024-2032)
Table Global Antibody Drug Conjugate Market Size and CAGR Forecast by Region (2024-2032)
Table Global Antibody Drug Conjugate Market Size and CAGR Forecast by Type (2024-2032)
Table Global Antibody Drug Conjugate Market Size and CAGR Forecast by Application (2024-2032)
Table Global Antibody Drug Conjugate Market Size and CAGR Forecast by Sales Channel (2024-2032)

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Antibody Drug Conjugate Market 2024-2030 by Player, Region, Type, Application and Sales Channel